-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Best of ASH

PhD Trainee
Program: General Sessions
Tuesday, December 12, 2017: 11:30 AM-1:00 PM
Bldg C, Lvl 1, Hall C2-C3 (Georgia World Congress Center)
Andrew S. Weyrich, PhD, University of Utah and Scott A. Armstrong, MD, PhD, Dana-Farber Cancer Institute
Armstrong: C4 Therapeutics: Consultancy; Imago: Consultancy; Cyteir: Consultancy; Epizyme: Consultancy.
Before heading home, make time to attend this 90-minute session for a review of the key themes from this year's meeting. Led by the 2017 Annual Meeting Scientific Program Co-Chairs, Best of ASH is your opportunity to hear about the biggest breakthroughs from the meeting's abstract presentations.

Andrew S. Weyrich, PhD

Program in Molecular Medicine, University of Utah, Salt Lake City, UT

Scott A. Armstrong, MD, PhD

Dana-Faber Cancer Institute, Boston, MA

See more of: General Sessions
<< Previous Session | Next Session >>